BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang H, Xia Y, Liu J, Ma Z, Shi Q, Yin J. Programmable release of 2-O-d-glucopyranosyl-l-ascorbic acid and heparin from PCL-based nanofiber scaffold for reduction of inflammation and thrombosis. Materials Today Chemistry 2020;17:100303. [DOI: 10.1016/j.mtchem.2020.100303] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Smith AA, Moore KBE, Ambs PM, Saraswati AP, Fortin JS. Recent Advances in the Discovery of Therapeutics to Curtail Islet Amyloid Polypeptide Aggregation for Type 2 Diabetes Treatment. Adv Biol (Weinh) 2022;:e2101301. [PMID: 35931462 DOI: 10.1002/adbi.202101301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chen Z, Jin Z, Yang L, Liu Y, Liu J, Cai S, Shen Y, Guo S. A self-expandable C-shaped 3D printing tracheal stent for combinatorial controlled paclitaxel release and tracheal support. Materials Today Chemistry 2022;24:100760. [DOI: 10.1016/j.mtchem.2021.100760] [Reference Citation Analysis]
3 Zhou Y, Lv X, Chen L, Zhang H, Zhu L, Lu Y, Chen X. Identification of Process-Related Impurities and Corresponding Control Strategy in Biocatalytic Production of 2-O-α-d-Glucopyranosyl-l-ascorbic Acid Using Sucrose Phosphorylase. J Agric Food Chem 2022. [PMID: 35412325 DOI: 10.1021/acs.jafc.2c00881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Li C, Wu P, Dou Y, Li Q, Zhang J. Bioresponsive nanoplatforms for imaging and therapy of cardiovascular diseases. VIEW 2022;3:20200137. [DOI: 10.1002/viw.20200137] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Bardoňová L, Kotzianová A, Skuhrovcová K, Židek O, Bártová T, Kulhánek J, Hanová T, Mamulová Kutláková K, Vágnerová H, Krpatová V, Knor M, Starigazdová J, Holomková P, Buffa R, Velebný V. Antimicrobial nanofibrous mats with controllable drug release produced from hydrophobized hyaluronan. Carbohydr Polym 2021;267:118225. [PMID: 34119178 DOI: 10.1016/j.carbpol.2021.118225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]